IGF2 Antikörper
-
- Target Alle IGF2 Antikörper anzeigen
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGF2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Neutralization (Neut)
- Marke
- IHC-plus™
- Spezifität
- Human IGF-II
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
E.coli derived recombinant Human IGF-II.
Type of Immunogen: Cell extract - Isotyp
- IgG
- Top Product
- Discover our top product IGF2 Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA (0.5 - 2 μg/mL), IHC, IHC-P (5 μg/mL), Neut (3 - 5 μg/mL), WB (0.1 - 0.2 μg/mL)
Usage: Immunohistochemistry: LS-B7415 in an IHC-plus antibody, validated by our pathologists for use in IHC against formalin-fixed, paraffin-embedded human tissues (IHC validation procedure). A concentration of 5 μg/mL is recommended. Neutralization: To yield one-half maximal inhibition [ND] of the biological activity of hIGF-II (10 ng/mL), a concentration of 3.1-4.6 μg/mL of this antibody is required. ELISA: To detect hIGF-II by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5-2 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IGF-II (LS-C104384) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of recombinant hIGF-II. Western Blot: To detect hIGF-II by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-II is 1.5-3 ng/lane, under either reducing or non-reducing conditions. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Sterile water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS, pH 7.2
- Handhabung
- Avoid freeze/thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store Lyophilized at room temperature up to 1 month
Reconstituted for up to 2 weeks at 2-8°C. Aliquot and freeze at -20°C for long term storage. Avoid freeze/thaw cycles.
-
- Target
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
- Andere Bezeichnung
- IGF2 (IGF2 Produkte)
- Synonyme
- C11orf43 antikoerper, IGF-II antikoerper, PP9974 antikoerper, LOC100136550 antikoerper, igf2 antikoerper, igf2b antikoerper, wu:fc26e03 antikoerper, zgc:91781 antikoerper, igf-2 antikoerper, insigf antikoerper, pp9974 antikoerper, AL033362 antikoerper, Igf-2 antikoerper, Igf-II antikoerper, M6pr antikoerper, Mpr antikoerper, Peg2 antikoerper, IGFII antikoerper, RNIGF2 antikoerper, IGF-II-B antikoerper, igf2-a antikoerper, igf2-b antikoerper, insulin like growth factor 2 antikoerper, insulin-like growth factor II antikoerper, insulin-like growth factor 2a antikoerper, insulin like growth factor 2 S homeolog antikoerper, insulin-like growth factor 2 antikoerper, insulin-like growth factor 2 (somatomedin A) antikoerper, insulin like growth factor 2 L homeolog antikoerper, IGF2 antikoerper, LOC100136550 antikoerper, igf2a antikoerper, igf2.S antikoerper, Igf2 antikoerper, igf2.L antikoerper
- Hintergrund
-
Name/Gene ID: IGF2
Family: Hormone
Synonyms: IGF2, C11orf43, Insulin-like growth factor II, IGF-II, PP9974, Somatomedin-A - Gen-ID
- 3481
- UniProt
- P01344
- Pathways
- Hormone Activity, Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Regulation of Carbohydrate Metabolic Process, Activated T Cell Proliferation
-